Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Annali Dell'Istituto Superiore Di Sanita|January 1, 1993
Chronobiologic assessment of antihypertensive therapyK Tamura, I Kohno, I Tsuruta, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|August 1, 1997
Subcutaneous transposition of the ovary following hysterectomyK Fujiwara, H Mohri, T Yoshida, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|June 7, 2000
Cytogenetic studies of Hynobiidae (Urodela) XVI. Comparative C-banded karyotype analysis of Pseudohynobius flavomaculatus (Fei et Ye), Ranodon shihi (Liu) and Batrachuperus pinchonii (David)C Ikebe, M Kuro, G Wu, et al.
Pathology International|December 31, 1997
Adenoid basal carcinoma of the cervix uteri: a case reportT Yoshida, K Fujiwara, M Shimizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 6, 2001
[A case of clear cell carcinoma of the ovary responding to a paclitaxel-carboplatin combination chemotherapy]K Fujiwara, K Maehata, I Kohno, et al.
Acta Cytologica|December 16, 1998
Adenocarcinoma in situ of the fallopian tube. A case reportH Minato, M Shimizu, M Hirokawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1989
[A case of ovarian germ cell tumor]R Hayase, T Tamada, Y Tao, et al.
Blood Pressure. Supplement|January 1, 1992
Efficacy of manidipine on circadian blood pressure in essential hypertensionT Nakamura, H Honma, I Kohno, et al.
Gynecologic Oncology|September 19, 1998
Relationship between peritoneal washing cytology through implantable port system (IPS-cytology) and second-look laparotomy in ovarian cancer patients with unmeasurable residual diseasesK Fujiwara, H Yamauchi, T Yoshida, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2005
Preliminary toxicity analysis of intraperitoneal carboplatin in combination with intravenous paclitaxel chemotherapy for patients with carcinoma of the ovary, peritoneum, or fallopian tubeK Fujiwara, S Suzuki, H Ishikawa, et al.
Pageof 10